Cinctive Capital Management LP Acquires Shares of 5,779 ICU Medical, Inc. $ICUI

Cinctive Capital Management LP acquired a new position in shares of ICU Medical, Inc. (NASDAQ:ICUI) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 5,779 shares of the medical instruments supplier’s stock, valued at approximately $693,000.

Several other institutional investors have also recently made changes to their positions in ICUI. SJS Investment Consulting Inc. lifted its position in shares of ICU Medical by 41,000.0% during the third quarter. SJS Investment Consulting Inc. now owns 411 shares of the medical instruments supplier’s stock valued at $49,000 after purchasing an additional 410 shares in the last quarter. Covestor Ltd grew its position in ICU Medical by 70.7% in the 3rd quarter. Covestor Ltd now owns 570 shares of the medical instruments supplier’s stock worth $68,000 after purchasing an additional 236 shares in the last quarter. Smartleaf Asset Management LLC increased its stake in ICU Medical by 11.6% in the 2nd quarter. Smartleaf Asset Management LLC now owns 969 shares of the medical instruments supplier’s stock valued at $128,000 after buying an additional 101 shares during the last quarter. Headlands Technologies LLC purchased a new stake in ICU Medical in the 2nd quarter valued at about $177,000. Finally, United Services Automobile Association bought a new position in shares of ICU Medical during the 1st quarter worth approximately $218,000. Institutional investors own 96.10% of the company’s stock.

Analysts Set New Price Targets

ICUI has been the topic of a number of research analyst reports. KeyCorp boosted their target price on ICU Medical from $175.00 to $180.00 and gave the stock an “overweight” rating in a research note on Friday, February 20th. Wall Street Zen upgraded ICU Medical from a “hold” rating to a “buy” rating in a report on Sunday, February 15th. Weiss Ratings reissued a “sell (d-)” rating on shares of ICU Medical in a research report on Thursday, January 22nd. Finally, Piper Sandler upped their price objective on ICU Medical from $172.00 to $178.00 and gave the company an “overweight” rating in a research note on Friday, February 20th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $179.33.

ICU Medical Trading Up 0.9%

Shares of ICUI stock opened at $126.96 on Tuesday. The company has a quick ratio of 1.15, a current ratio of 2.39 and a debt-to-equity ratio of 0.60. The firm has a market cap of $3.13 billion, a P/E ratio of 6,351.18, a PEG ratio of 1.82 and a beta of 0.79. The company has a 50 day moving average of $147.64 and a 200-day moving average of $138.16. ICU Medical, Inc. has a 12-month low of $107.00 and a 12-month high of $160.29.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings data on Thursday, February 19th. The medical instruments supplier reported $1.91 EPS for the quarter, beating the consensus estimate of $1.68 by $0.23. ICU Medical had a return on equity of 7.33% and a net margin of 0.03%.The business had revenue of $535.94 million for the quarter, compared to the consensus estimate of $541.20 million. During the same quarter in the prior year, the business earned $2.11 earnings per share. ICU Medical’s revenue for the quarter was down 14.1% on a year-over-year basis. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. Sell-side analysts anticipate that ICU Medical, Inc. will post 4.11 earnings per share for the current year.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.